Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells
Archives of Biochemistry and Biophysics · 2024-08 · 758 · 110075
DOI: 10.1016/j.abb.2024.110075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024-08. Verfasst von Yuko Mizukami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan. Hauptthemen laut MEDLINE: Claudins, Colorectal Neoplasms, Down-Regulation, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
An exceptional expression of claudins (CLDNs), tight junction (TJ) proteins, is observed in various solid cancer tissues. However, the pathophysiological roles of CLDNs have not been clarified in detail. CLDN14 is highly expressed in human colorectal cancer (CRC) tissues and cultured cancer epithelial cells. We found CLDN14 silencing decreased cell viability without affecting spheroid size in the three-dimensional (3D) spheroid model of DLD-1 cells derived from human CRC. Mitochondria activity and oxidative stress level were reduced by CLDN14 silencing. Furthermore, CLDN14 silencing decreased the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and its target antioxidative genes. CLDN14 was colocalized with ZO-1, a scaffolding protein in the TJ. CLDN14 silencing induced the disruption of TJ barrier such as the reduction of transepithelial electrical resistance and elevation of fluxes of small molecules including glucose in two-dimensional (2D) cultured model,. The depletion of glucose induced the elevation of ROS generation, mitochondria activity, and Nrf2 expression. These results suggest that CLDN14 increases Nrf2 expression in spheroids mediated via the formation of paracellular barrier to glucose. The cytotoxicities of doxorubicin, an anthracycline anticancer drug, and oxaliplatin, a platinum-based agent, were augmented by an Nrf2 activator in 2D cultured cells. The anticancer drug-induced toxicity was enhanced by CLDN14 silencing in 3D spheroids. We suggest that CLDN14 may potentiate chemoresistance mediated by the suppression of paracellular glucose permeability and activation of the Nrf2 signaling pathway in CRC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
- Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, 16-10 Kamishinano, Totsuka-ku, Yokohama, 244-0806, Japan.
- Laboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu, 502-8585, Japan.
- Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan. Electronic address: ikari@gifu-pu.ac.jp.
Zitieren
APA
Mizukami, Y., Ito, A., Hashimoto, S., Ando, T., Ishikawa, Y., Eguchi, H., Yoshino, Y., Matsunaga, T., & Ikari, A. (2024). Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells. Archives of Biochemistry and Biophysics, 758, 110075. https://doi.org/10.1016/j.abb.2024.110075
Vancouver
Mizukami Y, Ito A, Hashimoto S, Ando T, Ishikawa Y, Eguchi H, et al. Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells. Archives of Biochemistry and Biophysics. 2024;758:110075. doi:10.1016/j.abb.2024.110075
BibTeX
@article{Mizukami2024,
author = {Mizukami, Yuko and Ito, Ayaka and Hashimoto, Shotaro and Ando, Tomoka and Ishikawa, Yoshinobu and Eguchi, Hiroaki and Yoshino, Yuta and Matsunaga, Toshiyuki and Ikari, Akira},
title = {Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
volume = {758},
pages = {110075},
doi = {10.1016/j.abb.2024.110075}
}
EUVIMED